Lou Emil, Xiu Joanne, Baca Yasmine, Saeed Anwaar, Prakash Ajay, Gholami Sepideh, Subramanian Subbaya, Starr Timothy K, Fontana Elisa, Pandey Ritu, Lenz Heinz-Josef, Shields Anthony F, Nabhan Chadi, Oberley Matthew, Seeber Andreas, El-Deiry Wafik
Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Caris Life Sciences, Phoenix, AZ, USA.
Mol Ther Oncol. 2024 Feb 28;32(1):200786. doi: 10.1016/j.omton.2024.200786. eCollection 2024 Mar 21.
Oncogenic drivers such as extensively modulate the tumor inflammatory microenvironment (TIME) of colorectal cancer (CRC). The influence of on modulating immune cell composition remains unclear. The objective of this study was to identify signatures of infiltrative immune cells and distinctive patterns that differ between wild-type (WT) and oncogenic mutant (MT) CRC that explain immune evasion in MT tumors. A total of 7,801 CRC specimens were analyzed using next-generation DNA sequencing, whole-exome sequencing, and/or whole transcriptome sequencing. Deficiency of mismatch repair (dMMR)/microsatellite instability (MSI) and tumor mutation burden (TMB) were also assessed. mutations were present in 48% of CRC, similarly distributed in patients younger than vs. 50 years and older. In microsatellite stable (MSS) MT tumors, composition of the TIME included higher neutrophil infiltration and lower infiltration of B cells. MSI-H/dMMR was significantly more prevalent in WT (9.1%) than in MT (2.9%) CRC. In MSS CRC, TMB-high cases were significantly higher in RAS MT (3.1%) than in RAS WT (2.1%) tumors. and mutations are associated with increased neutrophil infiltration, with codon-specific differences. These results demonstrate significant differences in the TIME of mutant CRC that match previous reports of immunoevasive characteristics of such tumors.
诸如 等致癌驱动因素广泛调节结直肠癌(CRC)的肿瘤炎症微环境(TIME)。 对调节免疫细胞组成的影响尚不清楚。本研究的目的是确定浸润性免疫细胞的特征以及野生型(WT)和致癌突变型(MT)CRC之间不同的独特模式,这些模式可解释MT肿瘤中的免疫逃逸。使用下一代DNA测序、全外显子测序和/或全转录组测序对总共7801份CRC标本进行了分析。还评估了错配修复缺陷(dMMR)/微卫星不稳定性(MSI)和肿瘤突变负担(TMB)。 在48%的CRC中存在 突变,在50岁及以下与50岁以上患者中的分布相似。在微卫星稳定(MSS) 的MT肿瘤中,TIME的组成包括更高的中性粒细胞浸润和更低的B细胞浸润。MSI-H/dMMR在WT的CRC中(9.1%)比在MT的CRC中(2.9%)明显更普遍。在MSS CRC中,RAS MT肿瘤(3.1%)中TMB高的病例显著高于RAS WT肿瘤(2.1%)。 突变和 突变与中性粒细胞浸润增加相关,存在密码子特异性差异。这些结果表明, 突变型CRC的TIME存在显著差异,这与此前关于此类肿瘤免疫逃逸特征的报道相符。